Exact FDA event identifier

Event 69985

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: December 17, 2014
Product types: Drug
Classifications: Class II
Statuses: Terminated
Recalling firm wording: Neolpharma, Inc.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Alprazolam tablets, USP, CIV, 0.25 mg, Rx Only, a) 500 count bottle, b) 1000 count bottle, Distributed by: Greenstone LLC, Peapack, NJ, 07977, a) NDC 59762-3719-3, b) NDC 59762-3719-4.

D-0326-2015

Recall number: D-0326-2015
Initiated: December 17, 2014
Classification: Class II
Status: Terminated
Recalling firm: Neolpharma, Inc.
Quantity: 12,310 bottles

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug

Code information

Lot #: a) C100429, Exp 03/15, b) C120293, Exp 01/17

Distribution pattern

Nationwide